ATYR PHARMA INC (ATYR:NASDAQ)
$0.174 -0.0098 (-5.3319%)
Analysed ATYR PHARMA INC (ATYR:NASDAQ) News Sources
aTyr Pharma Revamps Efzofitimod Path With New Phase III Sarcoidosis Trial
12-05-2026
marketbeat.com
aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update
15-05-2026
yahoo.com
aTyr Pharma to Present Subgroup Analysis of Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis at WASOG 2026
15-07-2026
yahoo.com
aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD
07-08-2026
yahoo.com
Update: ATyr Pharma Fiscal Q2 Loss Narrows; Announces Restructuring Plans
07-08-2026
yahoo.com
aTyr Pharma Provides Update on Timing of Regulatory Response for Planned Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis
01-09-2026
yahoo.com
Sarcoidosis Market Forecast: Emerging Therapies and Increasing Disease Awareness to Drive Expansion by 2036 | DelveInsight
08-09-2026
yahoo.com
aTyr Pharma Announces Alignment with FDA on Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis
24-09-2026
yahoo.com
aTyr Pharma FDA Alignment Sets Protocol for Phase 3 Efzofitimod Study in Pulmonary Sarcoidosis
24-09-2026
advfn.com
aTyr Pharma Announces Publication Demonstrating Anti-Fibrotic Effects of ATYR0101 in the Journal of Biological Chemistry
13-10-2026
yahoo.com
What is the current price of ATYR PHARMA INC (ATYR:NASDAQ)?
The current price of ATYR PHARMA INC (ATYR:NASDAQ) is $0.174.
ATYR PHARMA INC (ATYR:NASDAQ) absolute price change since previous trading day?
The absolute price change of ATYR PHARMA INC (ATYR:NASDAQ) since the previous trading day is $-0.0098.
ATYR PHARMA INC (ATYR:NASDAQ) percentage price change since previous trading day?
The percentage price change of ATYR PHARMA INC (ATYR:NASDAQ) since the previous trading day is -5.3319%.
What is the most recent average sentiment score for ATYR PHARMA INC (ATYR:NASDAQ)?
The most recent average sentiment score for ATYR PHARMA INC (ATYR:NASDAQ) is 61 out of 100.
What is the most recent average sentiment for ATYR PHARMA INC (ATYR:NASDAQ)?
The most recent sentiment for ATYR PHARMA INC (ATYR:NASDAQ) is .
SEC-8K** Filing Available For ATYR PHARMA INC (ATYR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.